2015 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle View 
December 1, 2015Pernix Therapeutics to Present at Oppenheimer 26th Annual Healthcare Conference
November 13, 2015Pernix Therapeutics to Present at Stifel 2015 Healthcare Conference
November 12, 2015Pernix Therapeutics Holdings, Inc. Announces Positive Interim Results from a Phase IV Study to Assess and Compare the Effects of Silenor 6 mg and zolpidem 10 mg on Balance, Cognitive Performance, and Arousability
November 10, 2015Pernix Therapeutics to Host Meetings at Upcoming Conferences
November 5, 2015Pernix Therapeutics Reports Third Quarter 2015 Financial Results
October 22, 2015PERNIX THERAPEUTICS HOLDINGS, INC. TO REPORT THIRD QUARTER 2015 FINANCIAL RESULTS ON THURSDAY, NOVEMBER 5, 2015
September 24, 2015Pernix Announces the Issuance of Zohydro ER with BeadTek Formulation Patent
September 9, 2015Pernix Therapeutics Inc. to Present at Morgan Stanley Global Healthcare Conference
September 9, 2015Pernix Presents Data on Novel Extended Release Formulation of Hydrocodone Bitartrate at PAINWeek
August 24, 2015Pernix Therapeutics Announces New Revolving Credit Facility
August 6, 2015Pernix Therapeutics Reports Second Quarter 2015 Financial Results
July 27, 2015Pernix Releases Positive in vitro Abuse Deterrent Data for Third Generation Extended Release Hydrocodone ZX007
July 24, 2015Pernix Therapeutics Inc. to Report Second Quarter 2015 Financial Results On Thursday, August 6, 2015
June 23, 2015“Scandal” Star Bellamy Young Encourages Women to Take Control of Their Migraines During National Migraine Awareness Month
June 15, 2015Pernix Therapeutics Inc. to Present at JMP Securities Life Sciences Conference
May 21, 2015Pernix Therapeutics Inc. to Present at Jefferies 2015 Healthcare Conference
May 15, 2015FDA Approves TREXIMET (sumatriptan and naproxen sodium) for Use in Pediatric Patients
May 5, 2015Pernix Releases Pharmacokinetic Data for ZX007 Third Generation Zohydro ER on Track
May 4, 2015Pernix Launches Zohydro® ER with BeadTek™
May 1, 2015Pernix Therapeutics Inc. Reports First Quarter 2015 Financial Results
April 24, 2015Pernix Therapeutics Closes Acquisition of Zohydro ER Franchise
April 20, 2015Pernix Therapeutics Inc. Obtains Six Months U.S. Pediatric Exclusivity for Treximet
April 17, 2015PERNIX THERAPEUTICS ANNOUNCES PRICING OF PRIVATE OFFERING OF $130 MILLION OF 4.25% CONVERTIBLE SENIOR NOTES DUE 2021
April 17, 2015Pernix Therapeutics Inc. to Report First Quarter 2015 Financial Results
April 15, 2015PERNIX THERAPEUTICS ANNOUNCES PRIVATE OFFERING OF $120 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2021
April 15, 2015Pernix Therapeutics Provides Business Update
April 13, 2015PERNIX THERAPEUTICS ANNOUNCES LAUNCH OF CONSENT SOLICITATION FOR ITS 12% SENIOR SECURED NOTES DUE 2020